Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v4-EN
Language English English
Date Updated 2019-03-21 2019-02-26
Drug Identification Number 02363445 02363445
Brand name OZURDEX OZURDEX
Common or Proper name dexamethasone intravitreal implant dexamethasone intravitreal implant
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients DEXAMETHASONE DEXAMETHASONE
Strength(s) 0.7MG 0.7MG
Dosage form(s) IMPLANT IMPLANT
Route of administration INTRAVITREAL INTRAVITREAL
Packaging size 0.7MG 0.7MG
ATC code S01BA S01BA
ATC description ANTIINFLAMMATORY AGENTS ANTIINFLAMMATORY AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-02-25 2019-02-25
Actual start date 2019-03-04
Estimated end date 2019-03-25 2019-03-25
Actual end date 2019-03-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Rebuilding in country inventory levels following prior supply disruption Rebuilding in country inventory levels following prior supply disruption
Health Canada comments